NDAORALSPRAY, METERED
Approved
Dec 2008
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
3
Clinical Trials (3)
Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo
Started Jan 2006
36 enrolled
Insomnia
Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions
Started Mar 2002
24 enrolled
Healthy
Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions
Started Feb 2002
38 enrolled
Healthy
Loss of Exclusivity
LOE Date
Aug 7, 2032
78 months away
Patent Expiry
Aug 7, 2032
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 8236285 | Aug 7, 2032 | SubstanceProduct | U-70 |
Company
Aytu BioPharma
DENVER, CO
External Resources